Vaccinations are the best way to control the Covid-19 pandemic. There is now a global consensus about that. In China, vaccine production is thus progressing with great impetus. The WIKA subsidiary in Suzhou is an important partner in this for the pharmaceutical industry when it comes to high-quality measurement solutions for vaccine production.
In 2021, about three billion doses of vaccine will be produced in China to service the growing demand for immunisation. WIKA plays an indispensable role for production in this. The WIKA subsidiary supplies high-quality solutions for measuring pressure, temperature and level in bioreactors, fermenters, CIP/SIP systems, insulators, sterilisers and the production of pharmaceuticals-grade water. To date, all of the Covid-19 vaccine production lines at all the major pharmaceutical companies in China are equipped with WIKA instruments.
In-demand partner for measurement solutions for vaccine production
By the end of May, a considerable number of mechanical and electrical measuring instruments with diaphragm seals had been delivered − TR21 (resistance thermometers), PG43SA (hygienic diaphragm pressure gauges), A2G-50 (differential pressure sensors) and also UPT-20 (process transmitters) and DPT-10 (differential pressure transmitters). Further orders are expected.
Intense activity for the pharmaceutical division of WIKA China
In view of the high level of demand, WIKA China has mobilised additional manpower to expedite material supply and production. The team is working hard to secure the goal of quality control and on-time delivery. Everyone is proud of participating in the fight to protect people from the health implications of this pandemic.
Note
Further information on pharmaceuticals and biotechnology and also on pressure, temperature and level measurement can be found on the WIKA website. If you have any questions, your contact will gladly help you.
See also our post
Safe pressure monitoring for vaccine production